Anna A. Avagyan: Presenting Armenia’s Experience at SIOP Europe 2026
Anna A. Avagyan, Pediatric Hematologist/Oncologist at Pediatric Cancer and Blood Disorders Center of Armenia, shared a post on LinkedIn:
”SIOP Europe 2026 was a great mix of strong science and real-world clinical discussion – the kind of meeting where you come back with new ideas, better questions, and renewed energy from the people around you.
This year, I presented a clinical case from our center in Armenia in the Young SIOP session on childhood cancer predisposition syndromes.
I shared our experience with therapeutic decision-making in a child with an underlying genetic predisposition and significant treatment vulnerability-highlighting how ‘host biology’ can redefine what is feasible and safe when standard pathways are limited.
SIOP-E was also a great chance to reconnect with the network and to meet new colleagues and friends.
Thank you to everyone involved in this patient’s care and to the wider community advancing pediatric oncology through collaboration and shared learning.
Special thanks to the H. Hovnanian Family Foundation Armenia for supporting my participation at SIOP Europe.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 12:14Garima Sharma: Community Clinical Linkages for Better Postpartum Cardiovascular Care
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?